These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7377131

  • 1. Measurement of antithrombin III in normal and pathologic states using chromogenic substrate S-2238. Comparison with immunoelectrophoretic and factor Xa inhibition assays.
    Goodnight SH, Schaeffer JL, Sheth K.
    Am J Clin Pathol; 1980 May; 73(5):639-47. PubMed ID: 7377131
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J, von Pape KW, Blaurock M.
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [Abstract] [Full Text] [Related]

  • 10. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.
    de Moerloose PA, Reber G, Vernet P, Minazio P, Bouvier CA.
    Thromb Haemost; 1987 Apr 07; 57(2):154-7. PubMed ID: 3603409
    [Abstract] [Full Text] [Related]

  • 11. Revisiting antithrombin in health and disease, congenital deficiencies and genetic variants, and laboratory studies on α and β forms.
    Amiral J, Seghatchian J.
    Transfus Apher Sci; 2018 Apr 07; 57(2):291-297. PubMed ID: 29784539
    [Abstract] [Full Text] [Related]

  • 12. Rapid determination of five coagulation parameters in one sample with a centrifugal analyzer.
    Bas BM, Costongs GM, Janson PC.
    Haemostasis; 1987 Apr 07; 17(5):260-7. PubMed ID: 3478286
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antifactor Xa activity measured with amidolytic methods.
    Odegård OR, Lie M, Abildgaard U.
    Haemostasis; 1976 Apr 07; 5(5):265-75. PubMed ID: 1017722
    [Abstract] [Full Text] [Related]

  • 15. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM, Barrowcliffe TW, Thomas DP.
    Thromb Haemost; 1982 Apr 30; 47(2):104-8. PubMed ID: 6179182
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Improved assay conditions for automated antithrombin III determinations with the chromogenic substrate S-2238.
    van Voorthuizen H, Kluft C.
    Thromb Haemost; 1984 Dec 29; 52(3):350-3. PubMed ID: 6531759
    [Abstract] [Full Text] [Related]

  • 19. [Heparin assay in plasma. Comparison of different methods (author's transl)].
    Vinazzer H.
    Anaesthesist; 1979 Jun 29; 28(6):299-303. PubMed ID: 464252
    [Abstract] [Full Text] [Related]

  • 20. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
    Tran TH, Bondeli C, Marbet GA, Duckert F.
    Thromb Haemost; 1980 Oct 31; 44(2):92-5. PubMed ID: 7455997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.